2012
DOI: 10.1039/c2dt32039h
|View full text |Cite
|
Sign up to set email alerts
|

Fluorescent azadipyrrinato zinc(ii) complex: hybridisation with a dipyrrinato ligand

Abstract: We synthesised heteroleptic azadipyrrinato-dipyrrinato hybrid zinc(II) complex 1-Zn-2, by means of the stepwise coordination method. Homoleptic bis(azadipyrrinato)zinc(II) complex 1-Zn-1 was non-fluorescent, whereas 1-Zn-2 exhibited detectable fluorescence from azadipyrrinato ligand 1.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 25 publications
0
25
0
Order By: Relevance
“…This electronic structure leads to the suppression of non‐emissive symmetry‐breaking charge separation . The validity of our strategy has been further verified by heteroleptic tris(dipyrrinato)indium(III) and (azadipyrrinato)(dipyrrinato)zinc(II) complexes that also show brighter luminescence than the corresponding homoleptic complexes. The limitation of this strategy is clear when attempting to gain bright fluorescence from a simple, non‐π‐expanded dipyrrinato ligand (for example, the left‐hand dipyrrinato ligand of 1 in Figure a).…”
Section: Figurementioning
confidence: 99%
“…This electronic structure leads to the suppression of non‐emissive symmetry‐breaking charge separation . The validity of our strategy has been further verified by heteroleptic tris(dipyrrinato)indium(III) and (azadipyrrinato)(dipyrrinato)zinc(II) complexes that also show brighter luminescence than the corresponding homoleptic complexes. The limitation of this strategy is clear when attempting to gain bright fluorescence from a simple, non‐π‐expanded dipyrrinato ligand (for example, the left‐hand dipyrrinato ligand of 1 in Figure a).…”
Section: Figurementioning
confidence: 99%
“…Despite much progress in the tuning of the photophysical properties of these complexes, the corresponding BODIPY complexes remain the best of the class. [19][20][21][22][23][24] Next to applications as fluorescent probes, dipyrrin complexes and especially BODIPY complexes have also recently received attention for their utilisation as photosensitizers (PSs) for photodynamic therapy (PDT) for the treatment of bacterial, fungal or viral infections as well as various types of cancer (e.g., lung, bladder, oesophageal, and brain cancer). [25][26][27][28][29][30] During a PDT treatment, a PS is injected, either locally or systemically.…”
Section: Introductionmentioning
confidence: 99%
“…[36][37][38][39][40][41][42][43][44][45][46] Typically, complexes are formed under mild rt conditions in THF with t-butoxide or DIPEA as base. This points to an ever expanding future for these complexes not just for their own inherent properties but also for catalysis and material applications.…”
Section: 35mentioning
confidence: 99%